Integrated Core Strategies (US) LLC 13D/13G Filings for Kindred Biosciences, Inc. (KIN)

Integrated Core Strategies (US) LLC 13D and 13G filings for Kindred Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-06-24
4:21 pm
Purchase
2021-06-17 13G Kindred Biosciences, Inc.
KIN
Integrated Core Strategies (US) LLC 2,579,698
5.700%
2,579,698increase
(New Position)
Filing